Northern Trust’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $676K | Sell |
14,314
-17
| -0.1% | -$802 | ﹤0.01% | 3551 |
|
|
2025
Q1 | $560K | Buy |
14,331
+70
| +0.5% | +$2.74K | ﹤0.01% | 3530 |
|
|
2024
Q4 | $772K | Buy |
14,261
+8,811
| +162% | +$477K | ﹤0.01% | 3503 |
|
|
2024
Q3 | $275K | Buy |
5,450
+573
| +12% | +$28.9K | ﹤0.01% | 3774 |
|
|
2024
Q2 | $214K | Sell |
4,877
-837
| -15% | -$36.8K | ﹤0.01% | 3846 |
|
|
2024
Q1 | $287K | Sell |
5,714
-1,488
| -21% | -$74.7K | ﹤0.01% | 3760 |
|
|
2023
Q4 | $435K | Buy |
7,202
+1,465
| +26% | +$88.5K | ﹤0.01% | 3581 |
|
|
2023
Q3 | $327K | Buy |
+5,737
| New | +$327K | ﹤0.01% | 3635 |
|